News

Selected by the coaches Division I First Team Hannah Lisauskas, attack, Pinkerton; Delaney Summers, attack, Pinkerton; Maddie Kiely, attack, Bedford; Raegan Lawton, attack, Portsmouth; Carly Benzekri, ...
SOFTBALL ALL-SCHOLASTICS Aniyah Bailey (Taunton) Kelsey Blanchette (Lincoln-Sudbury) Bella Bourque (Taunton) Molly Burns (Wakefield) Camryn Cloonan (Dighton-Rehoboth) Madolyn Coupal (Bishop Feehan ...
Several hundred seniors graduated from Braintree High School on Saturday, June 7, from Alumni Stadium. Addresses were given by class president Emily Tran, student council president Caitlyn Chang ...
INDIANAPOLIS, June 23, 2025 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2025 of $1.50 per ...
Nova Scotia's Royal Canadian Mounted Police (RCMP) announced on Wednesday that investigators have conducted polygraph interviews as part of the effort to determine what happened to Lilly and Jack ...
Telehealth partners for Eli Lilly (LLY) continue to sell compounded GLP-1 weight-loss drugs despite an agreement with the pharma giant to end copycat sales after the FDA ended a years-long ...
An experimental weight-loss drug from Eli Lilly & Co. helped patients lose weight with few side effects, according to the summary of a small study that suggests the company has another foothold in ...
Eli Lilly (NYSE:LLY) lands an $870 million pact with Camurus (CAMX) to build long-acting obesity treatments, tapping FluidCrystalslow-release tech to stretch dosing from days to weeks. Lilly's ...
Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and the company aims to announce in the third quarter trial results for the ...
In recent times, though, Lilly has become less expensive, as the stock slipped 12% from a high reached in March. Is Lilly a buy on the dip? Let's find out. Image source: Getty Images.
Eli Lilly & Co. will only work with telehealth firms that agree to stop selling copycat versions of weight-loss drugs, diminishing the likelihood of a partnership with one most visible players ...